115 related articles for article (PubMed ID: 435383)
1. Histopathology of remodelling induced by PUVA in the superficial dermis.
Pierard GE; Ackerman AB
Br J Dermatol; 1979 Mar; 100(3):251-6. PubMed ID: 435383
[TBL] [Abstract][Full Text] [Related]
2. The effect of photochemotherapy on epidermal-glycogen and on capillaries in psoriatic skin.
Vukas A; Batistić B; Velfl D
Dermatologica; 1978; 157(2):86-90. PubMed ID: 668974
[TBL] [Abstract][Full Text] [Related]
3. Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes.
Hashimoto K; Kohda H; Kumakiri M; Blender SL; Willis I
Arch Dermatol; 1978 May; 114(5):711-22. PubMed ID: 646392
[TBL] [Abstract][Full Text] [Related]
4. [Formation of dermo-epidermal hyperplasia in psoriasis].
Pierard GE; Pierard-Franchimont C
Ann Dermatol Venereol; 1983; 110(11):891-7. PubMed ID: 6666933
[TBL] [Abstract][Full Text] [Related]
5. Effects of PUVA on the epidermal melanocyte population in psoriatic patients.
Rosdahl IK; Swanbeck G
Acta Derm Venereol; 1980; 60(1):21-6. PubMed ID: 6153829
[TBL] [Abstract][Full Text] [Related]
6. Morphologic changes in epidermis of PUVA-treated patients with psoriasis with or without a history of arsenic therapy.
Niemi KM; Niemi A; Kanerva L
Arch Dermatol; 1983 Nov; 119(11):904-9. PubMed ID: 6639110
[TBL] [Abstract][Full Text] [Related]
7. A semiquantitative light and electron microscopic analysis of histopathologic changes in photochemotherapy-induced freckles.
Kanerva L; Niemi KM; Lauharanta J
Arch Dermatol Res; 1984; 276(1):2-11. PubMed ID: 6703775
[TBL] [Abstract][Full Text] [Related]
8. [Histopathology and histochemistry of psoriasis under photochemotherapy (author's transl)].
Braun-Falco O; Hofmann C; Plewig G
Arch Dermatol Res (1975); 1977 Jan; 257(3):307-17. PubMed ID: 836079
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
Brazzelli V; Barbagallo T; Prestinari F; Rona C; De Silvestri A; Trevisan V; Borroni G
Int J Immunopathol Pharmacol; 2005; 18(4):755-60. PubMed ID: 16388725
[TBL] [Abstract][Full Text] [Related]
10. Colloid-amyloid bodies in PUVA-treated human psoriatic patients.
Hashimoto K; Kumakiri M
J Invest Dermatol; 1979 Feb; 72(2):70-80. PubMed ID: 422871
[TBL] [Abstract][Full Text] [Related]
11. Mast cell density in psoriatic skin. The effect of PUVA and corticosteroid therapy.
Töyry S; Fräki J; Tammi R
Arch Dermatol Res; 1988; 280(5):282-5. PubMed ID: 3178285
[TBL] [Abstract][Full Text] [Related]
12. Abnormal maturation pathway of keratinocytes in psoriatic skin.
Bernard BA; Robinson SM; Vandaele S; Mansbridge JN; Darmon M
Br J Dermatol; 1985 Jun; 112(6):647-53. PubMed ID: 3890921
[TBL] [Abstract][Full Text] [Related]
13. Resolution of psoriatic lesions in erythematous skin induced by PUVA treatment.
Vukas A; Batistić B; Zambal Z
Acta Med Iugosl; 1979; 33(2):147-53. PubMed ID: 506793
[No Abstract] [Full Text] [Related]
14. In vivo autoradiography and planimetry of epidermis in psoriatics under PUVA-therapy.
Hofmann C; Landthaler M; Plewig G; Braun-Falco O
Arch Dermatol Res; 1980; 267(1):61-70. PubMed ID: 7387176
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandins in PUVA-treated psoriasis.
Heiligstädt H; Kassis B; Weismann K; Søndergaad J
Acta Derm Venereol; 1978; 58(3):213-6. PubMed ID: 78634
[TBL] [Abstract][Full Text] [Related]
16. Photofibrosis: a further histopathological change induced by PUVA therapy via the mast cell in guttate psoriasis. Preliminary report.
Borroni G; Vignati G; Zaccone C; Gorani A; Brazzelli V; Rabbiosi G
Acta Derm Venereol Suppl (Stockh); 1994; 186():159-61. PubMed ID: 8073822
[TBL] [Abstract][Full Text] [Related]
17. [PUVA therapy: long-term degenerative effects. I. Histological changes observed after PUVA therapy].
Torras H; Lecha M; Mascaró JM
Med Cutan Ibero Lat Am; 1987; 15(1):63-70. PubMed ID: 3298885
[TBL] [Abstract][Full Text] [Related]
18. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
Yamamoto T; Nishioka K
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and histological evaluation of oral psoralen plus UV-A exposure (PUVA) for treating psoriasis vulgaris (author's transl)].
Jimbow K; Nishio C; Uesugi T; Katoh M; Kato M; Makita A; Chiba M; Horikoshi T
Nihon Hifuka Gakkai Zasshi; 1978; 88(1):23-36. PubMed ID: 306462
[No Abstract] [Full Text] [Related]
20. Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasis.
Schmoll M; Henseler T; Christophers E
Br J Dermatol; 1978 Dec; 99(6):693-702. PubMed ID: 737132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
